Date published: 2025-10-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

Cefoperazone acid (CAS 62893-19-0)

0.0(0)
Write a reviewAsk a question

See product citations (1)

Application:
Cefoperazone acid is an antimicrobial β-lactamase inhibitor
CAS Number:
62893-19-0
Purity:
≥98%
Molecular Weight:
645.47
Molecular Formula:
C25H27N9O8S2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Cefoperazone Acid, a broad-spectrum, third-generation cephalosporin, is a semisynthetic compound known for its antibacterial activity. By binding to penicillin-binding proteins (PBPs) situated on the inner membrane of bacterial cells, Cefoperazone Acid effectively renders them inactive. PBPs play a role in the final stages of constructing the bacterial cell wall and reshaping it during growth and division. Through the inactivation of PBPs, the essential cross-linkage of peptidoglycan chains necessary for the strength and rigidity of the bacterial cell wall is disrupted. Consequently, the integrity of the bacterial cell wall weakens, leading to cell lysis and destruction. This antibacterial mechanism highlights Cefoperazone Acid′s efficacy against a broad range of bacterial infections. Moreover, cefoperazone Acid, a related compound, exhibits potent inhibitory properties against LACTB (β-lactamase), an enzyme responsible for antibiotic resistance. This additional feature enhances Cefoperazone Acid′s antimicrobial activity by countering the mechanisms employed by certain bacteria to evade β-lactam antibiotics.


Cefoperazone acid (CAS 62893-19-0) References

  1. Inhibition of the class C beta-lactamase from Acinetobacter spp.: insights into effective inhibitor design.  |  Drawz, SM., et al. 2010. Biochemistry. 49: 329-40. PMID: 19925018
  2. Neutrophil-Mediated Delivery of Therapeutic Nanoparticles across Blood Vessel Barrier for Treatment of Inflammation and Infection.  |  Chu, D., et al. 2015. ACS Nano. 9: 11800-11. PMID: 26516654
  3. Novel nanoparticulate drug delivery systems.  |  Friedrich, RP., et al. 2016. Nanomedicine (Lond). 11: 573-6. PMID: 26911384
  4. Leukocyte-mediated Delivery of Nanotherapeutics in Inflammatory and Tumor Sites.  |  Dong, X., et al. 2017. Theranostics. 7: 751-763. PMID: 28255364
  5. Neutrophil-mediated delivery of nanotherapeutics across blood vessel barrier.  |  Dong, X., et al. 2018. Ther Deliv. 9: 29-35. PMID: 29216803
  6. Biogenic and Biomimetic Carriers as Versatile Transporters To Treat Infections.  |  Goes, A. and Fuhrmann, G. 2018. ACS Infect Dis. 4: 881-892. PMID: 29553240
  7. Neutrophil-Based Drug Delivery Systems.  |  Chu, D., et al. 2018. Adv Mater. 30: e1706245. PMID: 29577477
  8. Neutrophil-Based Delivery Systems for Nanotherapeutics.  |  Han, Y., et al. 2018. Small. 14: e1801674. PMID: 30144279
  9. Targeting of Nanotherapeutics to Infection Sites for Antimicrobial Therapy.  |  Dong, X., et al. 2019. Adv Ther (Weinh). 2: PMID: 33313384
  10. Bioactive nanotherapeutic trends to combat triple negative breast cancer.  |  Chowdhury, P., et al. 2021. Bioact Mater. 6: 3269-3287. PMID: 33778204
  11. An insight into the inhibitory mechanism of phytochemicals and FDA-approved drugs on the ACE2-Spike complex of SARS-CoV-2 using computational methods.  |  Jani, V., et al. 2021. Chem Zvesti. 75: 4625-4648. PMID: 33994655
  12. The Repurposed ACE2 Inhibitors: SARS-CoV-2 Entry Blockers of Covid-19.  |  Ahmad, I., et al. 2021. Top Curr Chem (Cham). 379: 40. PMID: 34623536
  13. Combining nanotechnology with the multifunctional roles of neutrophils against cancer and inflammatory disease.  |  Tang, L., et al. 2022. Nanoscale. 14: 1621-1645. PMID: 35079756
  14. Blood cell-based drug delivery systems: A biomimetic platform for antibacterial therapy.  |  Rong, R., et al. 2022. Eur J Pharm Biopharm. 177: 273-288. PMID: 35868489
  15. Usage of Nanoparticles to Alter Neutrophils' Function for Therapy.  |  Wang, J., et al. 2022. ACS Biomater Sci Eng. 8: 3676-3689. PMID: 36018296

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Cefoperazone acid, 1 g

sc-204677
1 g
$54.00

Cefoperazone acid, 5 g

sc-204677A
5 g
$153.00